Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × palbociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Sarcoma 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Sarcoma, Ewing 2 Oligodendroglioma 2 Medulloblastoma 2 Lymphoma 2 Glioma 2 Glioblastoma 2 Colonic Neoplasms 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡